Literature DB >> 33974912

Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.

Simone S Riedel1, Congcong Lu2, Hongbo M Xie3, Kevin Nestler1, Marit W Vermunt4, Alexandra Lenard1, Laura Bennett5, Nancy A Speck5, Ichiro Hanamura6, Julie A Lessard7, Gerd A Blobel8, Benjamin A Garcia2, Kathrin M Bernt9.   

Abstract

Meningioma-1 (MN1) overexpression in AML is associated with poor prognosis, and forced expression of MN1 induces leukemia in mice. We sought to determine how MN1 causes AML. We found that overexpression of MN1 can be induced by translocations that result in hijacking of a downstream enhancer. Structure predictions revealed that the entire MN1 coding frame is disordered. We identified the myeloid progenitor-specific BAF complex as the key interaction partner of MN1. MN1 over-stabilizes BAF on enhancer chromatin, a function directly linked to the presence of a long polyQ-stretch within MN1. BAF over-stabilization at binding sites of transcription factors regulating a hematopoietic stem/progenitor program prevents the developmentally appropriate decommissioning of these enhancers and results in impaired myeloid differentiation and leukemia. Beyond AML, our data detail how the overexpression of a polyQ protein, in the absence of any coding sequence mutation, can be sufficient to cause malignant transformation.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AML; BAF; IDP; IDR; Meningioma-1; SWI/SNF; intrinsically disordered protein/region; leukemia; polyQ

Mesh:

Substances:

Year:  2021        PMID: 33974912      PMCID: PMC8380056          DOI: 10.1016/j.molcel.2021.04.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   19.328


  81 in total

1.  Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.

Authors:  Jolanta Grembecka; Shihan He; Aibin Shi; Trupta Purohit; Andrew G Muntean; Roderick J Sorenson; Hollis D Showalter; Marcelo J Murai; Amalia M Belcher; Thomas Hartley; Jay L Hess; Tomasz Cierpicki
Journal:  Nat Chem Biol       Date:  2012-01-29       Impact factor: 15.040

2.  A SMARCD2-containing mSWI/SNF complex is required for granulopoiesis.

Authors:  Brittany C Michel; Cigall Kadoch
Journal:  Nat Genet       Date:  2017-04-26       Impact factor: 38.330

3.  Robust 4C-seq data analysis to screen for regulatory DNA interactions.

Authors:  Harmen J G van de Werken; Gilad Landan; Sjoerd J B Holwerda; Michael Hoichman; Petra Klous; Ran Chachik; Erik Splinter; Christian Valdes-Quezada; Yuva Oz; Britta A M Bouwman; Marjon J A M Verstegen; Elzo de Wit; Amos Tanay; Wouter de Laat
Journal:  Nat Methods       Date:  2012-09-09       Impact factor: 28.547

4.  Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes.

Authors:  Felicitas Thol; Haiyang Yun; Ann-Kathrin Sonntag; Frederik Damm; Eva M Weissinger; Jürgen Krauter; Katharina Wagner; Michael Morgan; Martin Wichmann; Gudrun Göhring; Gesine Bug; Oliver Ottmann; Wolf-Karsten Hofmann; Axel Schambach; Brigitte Schlegelberger; Torsten Haferlach; David Bowen; Ken Mills; Arnold Ganser; Michael Heuser
Journal:  Ann Hematol       Date:  2012-04-10       Impact factor: 3.673

5.  Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex.

Authors:  Michael Heuser; Haiyang Yun; Tobias Berg; Eric Yung; Bob Argiropoulos; Florian Kuchenbauer; Gyeongsin Park; Iyas Hamwi; Lars Palmqvist; Courteney K Lai; Malina Leung; Grace Lin; Anuhar Chaturvedi; Basant Kumar Thakur; Masayuki Iwasaki; Mikhail Bilenky; Nina Thiessen; Gordon Robertson; Martin Hirst; David Kent; Nicola K Wilson; Bertie Göttgens; Connie Eaves; Michael L Cleary; Marco Marra; Arnold Ganser; R Keith Humphries
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

6.  Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease.

Authors:  Douglas Ashley Monks; Jamie A Johansen; Kaiguo Mo; Pengcheng Rao; Bryn Eagleson; Zhigang Yu; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-02       Impact factor: 11.205

7.  Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

Authors:  Christian Langer; Guido Marcucci; Kelsi B Holland; Michael D Radmacher; Kati Maharry; Peter Paschka; Susan P Whitman; Krzysztof Mrózek; Claudia D Baldus; Ravi Vij; Bayard L Powell; Andrew J Carroll; Jonathan E Kolitz; Michael A Caligiuri; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

8.  The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription.

Authors:  Karel H M van Wely; Anco C Molijn; Arjan Buijs; Magda A Meester-Smoor; Albert Jan Aarnoudse; Anita Hellemons; Pim den Besten; Gerard C Grosveld; Ellen C Zwarthoff
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

9.  Coactivator condensation at super-enhancers links phase separation and gene control.

Authors:  Benjamin R Sabari; Alessandra Dall'Agnese; Ann Boija; Isaac A Klein; Eliot L Coffey; Krishna Shrinivas; Brian J Abraham; Nancy M Hannett; Alicia V Zamudio; John C Manteiga; Charles H Li; Yang E Guo; Daniel S Day; Jurian Schuijers; Eliza Vasile; Sohail Malik; Denes Hnisz; Tong Ihn Lee; Ibrahim I Cisse; Robert G Roeder; Phillip A Sharp; Arup K Chakraborty; Richard A Young
Journal:  Science       Date:  2018-06-21       Impact factor: 47.728

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  6 in total

Review 1.  Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.

Authors:  Lindsey E Montefiori; Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2021-10-23       Impact factor: 3.020

Review 2.  Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies.

Authors:  Richoo B Davis; Mahdi Muhammad Moosa; Priya R Banerjee
Journal:  Trends Cell Biol       Date:  2022-04-25       Impact factor: 21.167

3.  The BAFfling story of MN1-induced leukemogenesis.

Authors:  Aaron J Stonestrom; Ross L Levine
Journal:  Mol Cell       Date:  2021-06-03       Impact factor: 19.328

4.  FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion-like domains.

Authors:  Richoo B Davis; Taranpreet Kaur; Mahdi Muhammad Moosa; Priya R Banerjee
Journal:  Protein Sci       Date:  2021-06-04       Impact factor: 6.993

Review 5.  The oncogenic fusion landscape in pediatric CNS neoplasms.

Authors:  Mieke Roosen; Zelda Odé; Jens Bunt; Marcel Kool
Journal:  Acta Neuropathol       Date:  2022-02-15       Impact factor: 15.887

6.  Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes.

Authors:  Norman L Lehman; Nathalie Spassky; Müge Sak; Amy Webb; Cory T Zumbar; Aisulu Usubalieva; Khaled J Alkhateeb; Joseph P McElroy; Kirsteen H Maclean; Paolo Fadda; Tom Liu; Vineela Gangalapudi; Jamie Carver; Zied Abdullaev; Cynthia Timmers; John R Parker; Christopher R Pierson; Bret C Mobley; Murat Gokden; Eyas M Hattab; Timothy Parrett; Ralph X Cooke; Trang D Lehman; Stefan Costinean; Anil Parwani; Brian J Williams; Randy L Jensen; Kenneth Aldape; Akshitkumar M Mistry
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.